Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei
Melioidosis, caused by Burkholderia pseudomallei , is endemic in northeastern Thailand and Northern Australia. Severe septicemic melioidosis is associated with high levels of pro-inflammatory cytokines and is correlated with poor clinical outcomes. IL-10 is an immunoregulatory cytokine, which in oth...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2017-02, Vol.7 (1), p.42791-42791, Article 42791 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Melioidosis, caused by
Burkholderia pseudomallei
, is endemic in northeastern Thailand and Northern Australia. Severe septicemic melioidosis is associated with high levels of pro-inflammatory cytokines and is correlated with poor clinical outcomes. IL-10 is an immunoregulatory cytokine, which in other infections can control the expression of pro-inflammatory cytokines, but its role in melioidosis has not been addressed. Here, whole blood of healthy seropositive individuals (n = 75), living in N. E. Thailand was co-cultured with
B. pseudomallei
and production of IL-10 and IFN-γ detected and the cellular sources identified. CD3
−
CD14
+
monocytes were the main source of IL-10. Neutralization of IL-10 increased IFN-γ, IL-6 and TNF-α production and improved bacteria killing. IFN-γ production and microbicidal activity were impaired in individuals with diabetes mellitus (DM). In contrast, IL-10 production was unimpaired in individuals with DM, resulting in an IL-10 dominant cytokine balance. Neutralization of IL-10 restored the IFN-γ response of individuals with DM to similar levels observed in healthy individuals and improved killing of
B. pseudomallei in vitro
. These results demonstrate that monocyte derived IL-10 acts to inhibit potentially protective cell mediated immune responses against
B. pseudomallei,
but may also moderate the pathological effects of excessive cytokine production during sepsis. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep42791 |